New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ones for stronger treatment outcomes.

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...